In six of 10 studies examining the importance of disclosure, most patients and research participants reported believing financial ties should be disclosed. In the other four, about one-fourth of these populations believed ties should be disclosed. "Although many disclosure recipients want to know about financial ties, fewer believed that disclosure would affect their decision-making," the authors continue. "Most research participants were not concerned about physician financial ties with industry, with as few as 7 percent reporting concern in one study."
"As information on physician and researcher financial ties becomes more publicly available, further research is needed to explore the optimal format for widespread consumer use and the effect on patient decision-making in clinical care and research," they conclude.
(Arch Intern Med. 2010;170:675-682. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: Co-author Dr. Joffe served as a paid member of a Data and Safety Monitoring Committee for a Genzyme Corporation clinical trial. Dr. Gross has served as an expert witness. This study was supported by a Doris Duke Clinical Research Fellowship. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Disclosure Aids Transparency in Medicine
"During the past decade, a legion of biomedical ethicists, medical students, journalists and elected officials have demanded increased openness in the form of public reporting of financial relationships at the institutional, state a
|Contact: Karen Peart|
JAMA and Archives Journals